Clinical trials in sickle cell disease: Adopting the combination chemotherapy paradigm

This publication has 44 references indexed in Scilit:

• Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes
  Blood Reviews, 2007
• Protective effect of arginine on oxidative stress in transgenic sickle mouse models
  Free Radical Biology and Medicine, 2006
• Robust Vascular Protective Effect of Hydroxamic Acid Derivatives in a Sickle Mouse Model of Inflammation
  Microcirculation, 2006
• Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF‐β/BMP pathway
  British Journal of Haematology, 2006
• Unraveling the hemolytic subphenotype of sickle cell disease
  Blood, 2005
• Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
  New England Journal of Medicine, 2004
• Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin
  Blood, 2002
• Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent
  Medicine, 1996
• Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
  New England Journal of Medicine, 1995
• Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
  Journal of Clinical Investigation, 1984